Hynnova

Hynnova appears to be a legitimate early-stage project born from the EIT Digital 'Data Against COVID-19' initiative (associated with Hypermynds), focused on healthcare data analytics. However, the evaluation is severely impacted by the submission's inaccurate and hyperbolic claims. Specifically, the claim that 'most people have used my product' and the target audience is 'everyone' contradicts the specialized B2B nature of the solution. While the project has a valid origin story and verifiable backing from EIT Digital (2020), the submission fails to provide credible current traction metrics. The 'marketcap' figure is ambiguous and likely refers to valuation rather than revenue. The project receives credit for its underlying utility in healthcare but is heavily penalized for lack of verifiable growth signals and poor data quality.